The Role of Endoscopic Ultrasound in Evaluation of Patients With Indefinite Cause of Bile Duct Dilatation
Assistant Lecturer of Tropical Medicine and Gastroenterology
1 other identifier
interventional
50
1 country
1
Brief Summary
In the era of diagnostic imaging advances, Bile Duct Dilatation becomes a common incidental finding in patients present with either gastrointestinal symptoms or undergone the imaging study for any other complaints. Endoscopic ultrasound enables high resolution views of the biliary system, so it can help detection of different pathologies which cause bile duct dilatation and difficult to be detected by other imaging studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2022
CompletedFirst Posted
Study publicly available on registry
July 27, 2022
CompletedStudy Start
First participant enrolled
September 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJuly 27, 2022
July 1, 2022
2.2 years
July 20, 2022
July 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The percentage of patients with bile duct dilatation
Can EUS detect the cause of bile duct dilatation in patients not diagnosed by other imaging modalities
2 years
Study Arms (1)
patients with undiagnosed bile duct dilatation
OTHERpatients with bile duct dilation detected by imaging studies without revealing definite cause of obstruction
Interventions
Endoscopic ultrasound and biopsy intake of suspected lesions
Eligibility Criteria
You may qualify if:
- Prior inconclusive imaging studies of bile duct dilation.
- Common bile duct diameter of \>10 mm with prior cholecystectomy or \>7 mm without
You may not qualify if:
- Definite cause of obstruction stone, stricture, or mass on imaging studies (TUS, CT, MRCP or ERCP).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HMHamedlead
Study Sites (1)
AssiutU
Asyut, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hager Hamed, Master
Assiut University
Central Study Contacts
Hamed
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant lecturer of tropical medicine and gastroenterology
Study Record Dates
First Submitted
July 20, 2022
First Posted
July 27, 2022
Study Start
September 9, 2022
Primary Completion
December 1, 2024
Study Completion
August 1, 2025
Last Updated
July 27, 2022
Record last verified: 2022-07